Firefighters Exhibit Increased Cardiovascular Impairment

Share this content:
Firefighters Exhibit Increased Cardiovascular Impairment
Firefighters Exhibit Increased Cardiovascular Impairment

MONDAY, April 3, 2017 (HealthDay News) -- Exposure to fire is associated with activation of platelets, increased thrombus formation, and impaired vascular function, promoting myocardial ischemia and injury, according to a study published in the April 4 issue of Circulation.

Amanda L. Hunter, M.B., Ch.B., from the University of Edinburgh in the United Kingdom, and colleagues conducted an open-label crossover study involving 19 healthy firefighters who performed a standardized training exercise in a fire stimulation facility or light duties for 20 minutes.

The researchers found that core temperature increased and weight decreased after fire stimulation training (P < 0.001 for both). Exposure to fire simulation correlated with increased thrombus formation under low- and high-shear conditions compared with control (both P < 0.001), as well as increased platelet-monocyte binding (P = 0.03). A dose-dependent increase was seen in forearm blood flow with all vasodilators (P < 0.001); in response to acetylcholine and sodium nitroprusside, the increase was attenuated by fire simulation (P = 0.01 and 0.004). This correlated with an increase in fibrinolytic capacity, asymptomatic myocardial ischemia, and concentrations of plasma cardiac troponin I (P = 0.010).

"Our findings provide pathogenic mechanisms to explain the association between fire suppression activity and acute myocardial infarction in firefighters," the authors write.

Abstract/Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »